MedPath

Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients

Not Applicable
Completed
Conditions
Triple Pre-rehabilitation
Radiotherapy
Head and Neck Cancer
Registration Number
NCT05594069
Lead Sponsor
Peking University
Brief Summary

To evaluate the intervention effect of triple pre-rehabilitation on head and neck cancer patients with radiotherapy, and process evaluation to further optimize the intervention program.

The pre-rehabilitation intervention was develped previously based on the process of evidence-based-nursing, including interventions of nurtrtion, exercise, and psychology.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
87
Inclusion Criteria
  • 18≤ age < 75 years old
  • The pathological diagnosis of HNC included nasopharyngeal cancer, oral cancer, oropharyngeal cancer, hypopharyngeal cancer, laryngeal cancer, salivary gland cancer;
  • Plan to receive radiotherapy
  • Basic communication skills
  • Volunteer to participate in this study.
Exclusion Criteria
  • Combined with other malignant tumors
  • Distant metastasis
  • Inability to measure body composition, such as metal in the body or inability to stand alone
  • With contraindications to exercise (such as cardiovascular and cerebrovascular diseases, respiratory diseases, etc)
  • Complicated with severe liver and kidney function damage
  • Previous diagnosis of other cancers
  • pregnant or lactation women.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Critical weight lossAbout 6 weeks

Weight loss over 5% during radiotherapy

Secondary Outcome Measures
NameTimeMethod
Body composition measured by Bioelectrical Impedance Analysis (BIA)About 6 weeks

Body composition measured by Bioelectrical Impedance Analysis (BIA)

Rate of adverse reactions of radiotherapy assessed by CTCAE v5.0About 6 weeks

Adverse reactions of radiotherapy

Patients in the intervention group were interviewed about the compliance of the studyAbout 6 weeks

Patients in the intervention group were interviewed about the compliance of the study

Intake assessed by a simple diet self-assessment tool (SDSAT)About 6 weeks

Intake assessed by a simple diet self-assessment tool (SDSAT)

Number of participants with intervention-related adverse eventsAbout 6 weeks

Number of participants with intervention-related adverse events

Physical performanceAbout 6 weeks

Physical performance measured by hand grip strength

Quality of life of patients assessed by QLQ-C30About 6 weeks

Quality of life of patients assessed by QLQ-C30

Patients in the intervention group were interviewed about the experience of the studyAbout 6 weeks

Patients in the intervention group were interviewed about the experience of the study

Psychological status assessed by hospital anxiety and depression scale (HADS)About 6 weeks

Psychological status assessed by hospital anxiety and depression scale (HADS)

Trial Locations

Locations (1)

Tianjin medical university cancer institute and hospital

🇨🇳

Tianjin, China

Tianjin medical university cancer institute and hospital
🇨🇳Tianjin, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.